Class Action Lawsuits Filed Against Multiple Companies: Investors Alerted

Class Action Lawsuits Announced

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, has announced that class action lawsuits have been filed on behalf of shareholders of multiple companies, including Macrogenics, Inc. and Moderna, Inc. These legal actions highlight potential violations of federal securities laws, putting investors on alert 1

1

2

Macrogenics, Inc. Lawsuit Details

The class action lawsuit against Macrogenics, Inc. (NASDAQ: MGNX) is filed on behalf of individuals who purchased or acquired securities between February 15, 2023 and May 18, 2023. The lawsuit alleges that the company made materially false and misleading statements regarding its business, operations, and prospects 1

1

Moderna, Inc. Legal Action

Similarly, a class action lawsuit has been initiated against Moderna, Inc. (NASDAQ: MRNA) for shareholders who purchased or acquired securities between March 22, 2023 and April 4, 2023. The complaint accuses Moderna of making false and misleading statements about its business, operations, and compliance policies 2

2

Implications for Investors

These lawsuits have significant implications for investors who held securities in these companies during the specified periods. Shareholders may have the opportunity to recover damages and are encouraged to seek more information about their legal rights and potential recovery options 1

1

2

Role of Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C., with offices in New York and California, is spearheading these legal actions. The firm specializes in representing individual and institutional investors in complex litigation, including securities fraud and fiduciary duty matters 1

1

2

Related Stories

Class Action Lawsuits Filed Against Multiple Companies: Investors Alerted

Class Action Lawsuits Filed Against Multiple Tech Companies: CrowdStrike, DXC Technology, and Others in Focus

Class Action Lawsuit Deadlines Approach for CAE, AAL, ODD, and LFCR Investors

Class Action Lawsuit Deadlines Approach for CAE, AAL, ODD, and LFCR Investors

Next Steps for Affected Shareholders

Investors who purchased or acquired securities in Macrogenics, Inc. or Moderna, Inc. during the class periods are advised to contact the firm. Bragar Eagel & Squire, P.C. offers free case evaluations to help shareholders understand their rights and options 1

1

2

Broader Context of Securities Litigation

These lawsuits are part of a broader trend in securities litigation, where companies face legal challenges for alleged misrepresentations or omissions that may have affected stock prices. Such actions aim to protect investor interests and promote transparency in financial markets 1

1

2

Contact Information

For more information about these class action lawsuits or to discuss potential claims, shareholders are encouraged to visit Bragar Eagel & Squire, P.C.'s website or contact the firm directly. The firm's attorneys are available to address any questions or concerns investors may have regarding their rights and potential recovery in these cases 1

1

2